Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

386

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Donepezil
DRUG: AZD3480

Sponsor

Targacept Inc.